- Research works
- 8 ▲ 41% vs 2013–17
- Citations
- 91 11.6 per fractional work
- Top-10% rate
- 100.0% record average 16.5%
- Open access
- 26% world 28%
Not ranked overall: Siamab Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Siamab Therapeutics (United States) publish most on?
By volume in 2022–2025: Cell Adhesion Molecules Research, Glycosylation and Glycoproteins Research and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cell Adhesion Molecules Research Immunology and Allergy 0 works
- 2 Glycosylation and Glycoproteins Research Molecular Biology 0 works
- 3 Immunotherapy and Immune Responses Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Siamab Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 41% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Newton
- Newton Wellesley Hospital
- William James College
- Andover Newton Theological School
- Boston Psychoanalytic Society and Institute
- Barrett Technology (United States)
- Newton Public Schools
- Karyopharm Therapeutics (United States)
- Lasell College
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.